Research
Research focused on improving lymphoma treatments for Hispanics
June 15, 2020
Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin’s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients.
Cancer researcher relocates to lead early drug development at Mays Cancer Center
June 15, 2020
Cancer researcher Daruka Mahadevan, M.D., Ph.D., joins Mays Cancer Center and is leading early phase drug development. Dr. Mahadevan is concentrating on pancreatic cancer and lymphoma in his relocated lab.
Lung cancer tumors studied to discover new treatment, increase survival rate
June 15, 2020
Physician-scientist Josephine Taverna, M.D., is leading a multidisciplinary team performing advanced research with the goal of greatly increasing the survival rate for patients diagnosed with lung cancer.
Oncologist/investigator dedicates extensive career to drug development
June 14, 2020
While the Mays Cancer Center is dramatically increasing its early phase therapeutic development, John Sarantopoulos, M.D., has worked tirelessly researching next-generation cancer therapy since 2004.
Circle of Hope funds pilot project to improve survivors’ quality of life
June 14, 2020
A one-year pilot project is designed to prove the concept and initial effectiveness of a holistic, individualized yet structured approach to improve physical, mental and spiritual aspects of quality of life for survivors of all types of cancer.
FDA approves new drug to treat rare blood cancer myelofibrosis
June 14, 2020
Mays Cancer Center director is part of an international research team that developed a new drug to treat myelofibrosis, a rare blood cancer. The U.S. Food and Drug Administration approved the new drug.
Local clinician named 2019 MPN Hero for work on myeloproliferative neoplasms
June 14, 2020
CURE Media Group awarded a 2019 MPN Heroes award to Robyn Scherber, M.D., M.P.H., a nationally recognized clinician and hematologist, for her work in the field of rare blood cancers.
New Mays Cancer Center faculty and members
June 9, 2020
The Mays Cancer Center welcomes its new faculty and members to San Antonio, Texas.
Dr. Daruka Mahadevan earns national inventor award
June 8, 2020
Daruka Mahadevan, M.D., Ph.D., chief of the Division of Hematology and Medical Oncology in the Department of Medicine, was recognized as a senior member of the National Academy of Inventors.
NCI Outstanding Investigator Award presented to Dr. Patrick Sung
June 5, 2020
A highly competitive National Cancer Institute Outstanding Investigator Award was presented to Patrick Sung, D.Phil., for his research on BRCA1 and BRCA2 cancer biology.